8:45am ET
Investing
2 Biotech and 2 Tech Stocks Insiders Are Scooping Up Now
While insider buying has been slow lately, there have been some notable, large purchases at a couple of biotech companies, and e-commerce company.
Companies
/Healthcare
Cogent Biosciences Inc
$31.59
▼ $0.43 (−1.34%) today
Markets closed · 8:31pm ET
Fundamentals
Market Cap
$5.6B
EPS (TTM)
$-2.16
52-Week Range
$14 – $44
Street Target
$55.82
About Cogent Biosciences
Cogent Biosciences Inc, based in Waltham, Massachusetts, is a pioneering biotechnology firm dedicated to creating targeted treatments for genetic diseases. Its flagship product, bezuclastinib, is a cutting-edge therapy aimed at combating specific mutations in the KIT receptor tyrosine kinase, crucial for conditions like systemic mastocytosis and certain gastrointestinal stromal tumors. With a strategic partnership with Plexxikon Inc., Cogent is at the forefront of personalized medicine, transforming the landscape of treatment for patients with complex genetic disorders.
